Multihance at 3 Tesla (3T) in Brain Tumors

NCT00395863 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Tumor

Interventions

DRUG: Multihance
DRUG: Arm 2 - Magnevist

Sponsor

Bracco Diagnostics, Inc